In an exclusive interview with Yahoo Finance's Decoding Retirement podcast, Mehmet Oz, the administrator of the Centers for ...

The Trump administration is planning an experiment to cover weight loss drugs under Medicare and Medicaid, potentially ...

Dr. Mehmet Oz, administrator for the Centers for Medicare & Medicaid Services, discusses the Trump administration’s efforts ...

A five-year experiment aims to open access to blockbuster GLP‑1 drugs for obesity, something advocates have pushed for years.

Medicare and Medicaid could expand coverage of GLP-1 drugs, such as Ozempic and Wegovy, and pay for patients’ use of the ...

Blockbuster weight loss drugs like Wegovy and Zepbound have surged in popularity, but high prices have left them out of reach ...

AtlantiCare Chief Information Officer Jordan Ruch attended a White House summit with tech and healthcare leaders, joining ...

Medicaid turns 60 on July 30. CMS Administrator Mehmet Oz said Donald Trump's "big, beautiful bill" brings the program closer to its original intention.

Leadership at the Centers for Medicare and Medicaid Services is working with states to develop plans to use the $50 billion ...

Proposed experiment would allow states and Medicare drug plans to cover GLP-1 drugs like Ozempic and Wegovy for obesity, The ...

President Trump holds a "Making Health Technology Great" event at the White House with HHS Sec. Robert F. Kennedy Jr. and Dr.

The Odessa American is the leading source of local news, information, entertainment and sports for the Permian Basin.